Carson Wealth (CWM LLC)
PCRX icon

Carson Wealth (CWM LLC)’s Pacira BioSciences PCRX Stock Holding History

Carson Wealth (CWM LLC)’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$177K Sell
7,815
-42
-0.5% -$933 ﹤0.01% 2829
2025
Q4 		$203K Sell
7,857
-184
-2% -$4.38K ﹤0.01% 2568
2025
Q3 		$207K Sell
8,041
-1,362
-14% -$33.5K ﹤0.01% 2416
2025
Q2 		$225K Buy
9,403
+90
+1% +$2.27K ﹤0.01% 2070
2025
Q1 		$231K Buy
9,313
+16
+0.2% +$383 ﹤0.01% 1831
2024
Q4 		$175K Buy
9,297
+2,780
+43% +$48.8K ﹤0.01% 1912
2024
Q3 		$98K Buy
6,517
+5,716
+714% +$97.7K ﹤0.01% 2202
2024
Q2 		$23K Sell
801
-12
-1% -$342 ﹤0.01% 3029
2024
Q1 		$24K Buy
813
+51
+7% +$1.57K ﹤0.01% 2781
2023
Q4 		$26K Sell
762
-20
-3% -$585 ﹤0.01% 2602
2023
Q3 		$24K Sell
782
-672
-46% -$24.2K ﹤0.01% 2571
2023
Q2 		$58K Buy
1,454
+31
+2% +$1.28K ﹤0.01% 1876
2023
Q1 		$58K Buy
1,423
+980
+221% +$39K ﹤0.01% 1780
2022
Q4 		$17K Buy
443
+15
+4% +$730 ﹤0.01% 2484
2022
Q3 		$23K Buy
428
+100
+30% +$5.56K ﹤0.01% 2142
2022
Q2 		$19K Sell
328
-17
-5% -$1.11K ﹤0.01% 2152
2022
Q1 		$26K Buy
345
+30
+10% +$2K ﹤0.01% 1925
2021
Q4 		$19K Buy
+315
New +$17.4K ﹤0.01% 2025
2019
Q1 		– Sell
-9
Closed – – 3193
2018
Q4 		$0 Buy
+9
New +$420 ﹤0.01% 2208

Other funds holding PCRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DPCM
Doma Perpetual Capital Management Miami, Florida $431M AUM 13.21% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Carson Wealth (CWM LLC)'s PCRX Position: Q1 2026 in Review

Carson Wealth (CWM LLC) reduced its Pacira BioSciences (PCRX) stake by 0.53% in Q1 2026, selling an estimated $933 and leaving 7,815 shares worth $177K. The position accounts for ﹤0.01% of the portfolio, ranked #2829.

Carson Wealth (CWM LLC) first reported a position in PCRX in Q4 2018 and has held it in 19 quarters since. The position peaked at $231K in Q1 2025. 242 funds tracked by Wall St. Rank hold PCRX as of Q1 2026.

  • Carson Wealth (CWM LLC) held 7,815 shares of Pacira BioSciences worth $177K as of Q1 2026.
  • Carson Wealth (CWM LLC) sold 42 Pacira BioSciences shares in Q1 2026, an estimated $933.
  • Pacira BioSciences made up ﹤0.01% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #2829 holding.
  • Carson Wealth (CWM LLC) first reported a position in Pacira BioSciences in Q4 2018 and has held it in 19 quarters since.
  • Carson Wealth (CWM LLC)'s Pacira BioSciences position peaked at $231K in Q1 2025.
  • 242 funds tracked by Wall St. Rank held Pacira BioSciences as of Q1 2026.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.